Mallick Parag
SEC insider (Form 3/4/5 filer). CIK 0001857948. Chief Scientist at Nautilus Biotechnology, Inc. (NAUT). 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in SEATTLE, WA.
Companies Mallick Parag has filed insider reports for
- Nautilus Biotechnology, Inc. (NAUT): Director, Officer, 10% Owner, Chief Scientist
Mallick Parag
CIK: 0001857948
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Nautilus Biotechnology, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 2, 2026NAUT
Nautilus Biotechnology, Inc.
AwardDirectStock Option (Right to Buy)
280K shares- - May 12, 2025NAUT
Nautilus Biotechnology, Inc.
PurchaseDirect1.5K shares at avg. $0.73$1K - May 8, 2025NAUT
Nautilus Biotechnology, Inc.
PurchaseDirect12K shares at avg. $0.73$9K - Mar 3, 2025NAUT
Nautilus Biotechnology, Inc.
AwardDirectStock Option (Right to Buy)
280K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | NAUT Nautilus Biotechnology, Inc. | Award Stock Option (Right to Buy) | 280,000 | - | - | Direct |
| May 12, 2025 | NAUT Nautilus Biotechnology, Inc. | Purchase | 1,500 | $0.73 | $1,098 | Direct |
| May 8, 2025 | NAUT Nautilus Biotechnology, Inc. | Purchase | 12,000 | $0.73 | $8,788 | Direct |
| Mar 3, 2025 | NAUT Nautilus Biotechnology, Inc. | Award Stock Option (Right to Buy) | 280,000 | - | - | Direct |
1-4 of 4 transactions